About DPNCheck

Company Overview

DPNCheck®, originally developed as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996, is a rapid, point-of-care diagnostic device designed for the detection of peripheral neuropathies. In 2025, the product portfolio and its technology were acquired by The Electrode Store (TES) and Alera Medtech, strengthening its global reach and manufacturing capabilities.

DPNCheck's U.S. headquarters and manufacturing operations are based in Buckley, Washington. Learn more about the DPNCheck device and its capabilities.

Clinical Validation & Resources

DPNCheck's accuracy and reliability have been validated through extensive clinical research. View our comprehensive collection of peer-reviewed studies that demonstrate the device's clinical effectiveness. For comprehensive information about training materials, user manuals, and support resources, visit our resources section.

Questions about DPNCheck or interested in learning more? Contact our team for personalized assistance or see our FAQ page for more information.

Strategic Partnership

DPNCheck operates through a strategic partnership between The Electrode Store (TES) and Alera Medtech. This collaboration combines TES's manufacturing expertise and quality standards with Alera's global distribution network, ensuring healthcare professionals worldwide have access to reliable, high-quality peripheral neuropathy testing solutions.

TES, a subsidiary of Impulse Medical Technologies, brings decades of experience in neurodiagnostic device manufacturing, while Alera Medtech provides extensive international market access and distribution capabilities. Together, they form a powerful alliance dedicated to advancing medical diagnostics and improving patient care globally.